Overview

Glucocorticoid Receptor Antagonism in Subclinical Cushings

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of reducing the activity of endogenous glucocorticoid in patients with low-grade cortisol excess
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sheffield Teaching Hospitals NHS Foundation Trust
Collaborator:
HRA Pharma
Treatments:
Glucocorticoids
Mifepristone